Candid Therapeutics is a privately held biopharmaceutical company focused on the discovery and development of novel therapeutic candidates and biologic medicines. The company advances programs through translational research, preclinical development and early clinical activities, and collaborates with partners to progress treatments toward regulatory milestones and patient access.
Leadership & Board
Current Number of Employees36
Current LinkedIn Followers8,814
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$370M
Total Amount Raised$370M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$370M
Latest Funding Amount$370M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Candid Therapeutics had 36 employees as of October 5, 2026. The number of employees increased by 0 (0.00%) week-over-week.
36Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Candid Therapeutics had 8,814 followers as of October 5, 2026. The number of followers increased by 20 (0.23%) week-over-week.
8,814Latest Followers Count
20(0.23%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.
Funding Round
Oct 09, 2024
Series A
$370.00M
―
Investors
Series A
Similar Companies
A snapshot of private companies similar to Candid Therapeutics, helping you discover and navigate related company profiles.
Related News and Analysis
